Coronary Artery Disease and Heart Failure-Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management.
- 1. Department of Cardiology, Bluhm Cardiovascular Institute, Northwestern Medicine, Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: Jyothy.puthumana@nm.org.
- 2. Division of Cardiovascular Medicine, Internal Medicine, The Ohio State University, Wexner Medical Center, 473 West 12th Avenue, #200, Columbus, OH 43210, USA. Electronic address: rrbaliga@gmail.com.
- 3. Ohio State University
- 4. Department of Public Health, Department of Internal Medicine, Interdepartmental Center for Gender Medicine Research (GENESIS), Cardiovascular Disease Fellowship Program, Cardiovascular Pathophysiology and Therapeutics (CardioPath) Ph.D Program, UNESCO Chair on Health Education and Sustainable Development, Faculty of Medicine - University of Naples "Federico II", Italy. Electronic address: eduardo.bossone@unina.it.
- 5. University of Naples Federico II
Publication Details
Other
References
Huang . Association between coronary artery disease testing in patients with new...
Read more
Zheng . Variability in coronary artery disease testing for patients with new-ons...
Read more
Vedin . Significance of ischemic heart disease in patients with heart failure an...
Read more
Panza . Myocardial viability assessment before surgical revascularization in isc...
Read more
Roger . Epidemiology of heart failure: a contemporary perspective, Circ Res. 202...
Read more
Showing first 5 of 10 references.
Scholarly Citations
Cited by other scholarly works
115-275-365-111-25X
Read more
Showing first 1 of 1 scholarly citations.